SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-043740
Filing Date
2019-11-18
Accepted
2019-11-18 16:06:20
Documents
12
Period of Report
2019-11-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K dvax-8k_20191112.htm   iXBRL 8-K 33149
  Complete submission text file 0001564590-19-043740.txt   163016

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA dvax-20191112.xsd EX-101.SCH 5964
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE dvax-20191112_lab.xml EX-101.LAB 19475
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dvax-20191112_pre.xml EX-101.PRE 11627
6 EXTRACTED XBRL INSTANCE DOCUMENT dvax-8k_20191112_htm.xml XML 3549
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 191227627
SIC: 2834 Pharmaceutical Preparations